SCHEMBL16848251

SCHEMBL16848251

COc1ccc2c(c1)CCN(c1ccc(OC(C)C)c(C)c1)C2=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AOC3 Q16853 7/20 0.43
▸ NPC1 O15118 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SRD5A1 P18405 1/20 0.38
▸ PRMT5 O14744 1/20 0.38
▸ WDR77 Q9BQA1 1/20 0.38
▸ CYP26A1 O43174 1/20 0.37
▸ EGFR P00533 1/20 0.37
▸ HTR2A P28223 1/20 0.36
▸ HTR2C P28335 1/20 0.36
▸ HTR2B P41595 1/20 0.36
▸ PDE4A P27815 1/20 0.36
▸ PDE4B Q07343 1/20 0.36
▸ PDE4C Q08493 1/20 0.36
▸ PDE4D Q08499 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16827429 0.82 AOC3 (0.48) AOC3NPC1PKMRAB9ASRD5A1
SCHEMBL16827356 0.82 AOC3 (0.45) AOC3NPC1PKMRAB9ASRD5A1
SCHEMBL16827483 0.81 AOC3 (0.43) AOC3NPC1PKMRAB9ACYP26A1
SCHEMBL16827383 0.81 AOC3 (0.46) AOC3SRD5A1CYP26A1HTR2AHTR2C
SCHEMBL16848202 0.80 AOC3 (0.61) AOC3NPC1PKMRAB9ASRD5A1
SCHEMBL16848248 0.80 AOC3 (0.48) AOC3NPC1PKMRAB9ASRD5A1
SCHEMBL16827452 0.79 AOC3 (0.47) AOC3NPC1PKMRAB9ASRD5A1
SCHEMBL16827346 0.77 AOC3 (0.47) AOC3NPC1PKMRAB9ASRD5A1
SCHEMBL16848189 0.77 AOC3 (0.44) AOC3NPC1PKMRAB9APRMT5
SCHEMBL16827362 0.77 PDE4A (0.55) AOC3NPC1PKMRAB9APDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015092634-A1 1,2,3,4-TETRAHYDROISOQUINOLINE COMPOUNDS AND COMPOSITIONS AS SELECTIVE ESTROGEN RECEPTOR ANTAGONISTS AND DEGRADERS NOVARTIS AG (CH) 2015-06-25 — — WO disclosed
Send feedback